These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 26260902)

  • 1. Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assay.
    Arnold A; Bahra M; Lenze D; Bradtmöller M; Guse K; Gehlhaar C; Bläker H; Heppner FL; Koch A
    Exp Mol Pathol; 2015 Oct; 99(2):344-53. PubMed ID: 26260902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.
    Ruzzenente A; Fassan M; Conci S; Simbolo M; Lawlor RT; Pedrazzani C; Capelli P; D'Onofrio M; Iacono C; Scarpa A; Guglielmi A
    Ann Surg Oncol; 2016 May; 23(5):1699-707. PubMed ID: 26717940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma.
    Dalmasso C; Carpentier W; Guettier C; Camilleri-Broët S; Borelli WV; Campos Dos Santos CR; Castaing D; Duclos-Vallée JC; Broët P
    BMC Cancer; 2015 Mar; 15():126. PubMed ID: 25879652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencing.
    Putra J; de Abreu FB; Peterson JD; Pipas JM; Mody K; Amos CI; Tsongalis GJ; Suriawinata AA
    Exp Mol Pathol; 2015 Oct; 99(2):240-4. PubMed ID: 26189129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease.
    Alvaro D; Bragazzi MC; Benedetti A; Fabris L; Fava G; Invernizzi P; Marzioni M; Nuzzo G; Strazzabosco M; Stroffolini T;
    Dig Liver Dis; 2011 Jan; 43(1):60-5. PubMed ID: 20580332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of WWOX expression in human extrahepatic cholangiocarcinoma.
    Wang M; Gu J; Wang Y; Gong B
    J Cancer Res Clin Oncol; 2009 Jan; 135(1):39-44. PubMed ID: 18629536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelotype analysis of intrahepatic cholangiocarcinoma.
    Kang YK; Kim YI; Kim WH
    Mod Pathol; 2000 Jun; 13(6):627-31. PubMed ID: 10874666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
    Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
    Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide single nucleotide polymorphism array analysis reveals recurrent genomic alterations associated with histopathologic features in intrahepatic cholangiocarcinoma.
    Huang WT; Weng SW; Wei YC; You HL; Wang JT; Eng HL
    Int J Clin Exp Pathol; 2014; 7(10):6841-51. PubMed ID: 25400767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in chemokine receptor CCR5 activity influence tumor cell biology in human cholangiocarcinoma cell lines.
    Yang J; Sontag D; Gong Y; Minuk GY
    Ann Hepatol; 2021; 21():100265. PubMed ID: 33045415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.
    Churi CR; Shroff R; Wang Y; Rashid A; Kang HC; Weatherly J; Zuo M; Zinner R; Hong D; Meric-Bernstam F; Janku F; Crane CH; Mishra L; Vauthey JN; Wolff RA; Mills G; Javle M
    PLoS One; 2014; 9(12):e115383. PubMed ID: 25536104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Increased Chromosome 7 Copy Number in Endoscopic Bile Duct Biopsy Specimens Is Predictive of a Poor Prognosis in Cholangiocarcinoma.
    Kato A; Naitoh I; Miyabe K; Hayashi K; Yoshida M; Hori Y; Natsume M; Jinno N; Asano G; Kato H; Kuno T; Takahashi S; Kataoka H
    Dig Dis Sci; 2018 Dec; 63(12):3376-3381. PubMed ID: 30206756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX4 is associated with poor prognosis in cholangiocarcinoma.
    Wang W; Zhang J; Zhan X; Lin T; Yang M; Hu J; Han B; Hu S
    Biochem Biophys Res Commun; 2014 Sep; 452(3):614-21. PubMed ID: 25181339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: a potential molecular marker for tumor metastasis.
    Loilome W; Wechagama P; Namwat N; Jusakul A; Sripa B; Miwa M; Kuver R; Yongvanit P
    Parasitol Int; 2012 Mar; 61(1):136-9. PubMed ID: 21763455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copy number aberrations in combined hepatocellular carcinoma and cholangiocarcinoma.
    You HL; Weng SW; Li SH; Wei YC; Sheu JJ; Chen CM; Huang WT
    Exp Mol Pathol; 2012 Jun; 92(3):281-6. PubMed ID: 22366251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide analysis of DNA copy number alterations and loss of heterozygosity in intracranial germ cell tumors.
    Terashima K; Yu A; Chow WY; Hsu WC; Chen P; Wong S; Hung YS; Suzuki T; Nishikawa R; Matsutani M; Nakamura H; Ng HK; Allen JC; Aldape KD; Su JM; Adesina AM; Leung HC; Man TK; Lau CC
    Pediatr Blood Cancer; 2014 Apr; 61(4):593-600. PubMed ID: 24249158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups.
    Simbolo M; Fassan M; Ruzzenente A; Mafficini A; Wood LD; Corbo V; Melisi D; Malleo G; Vicentini C; Malpeli G; Antonello D; Sperandio N; Capelli P; Tomezzoli A; Iacono C; Lawlor RT; Bassi C; Hruban RH; Guglielmi A; Tortora G; de Braud F; Scarpa A
    Oncotarget; 2014 May; 5(9):2839-52. PubMed ID: 24867389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma.
    McKay SC; Unger K; Pericleous S; Stamp G; Thomas G; Hutchins RR; Spalding DR
    HPB (Oxford); 2011 May; 13(5):309-19. PubMed ID: 21492330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.
    Li M; Ouyang L; Zheng Z; Xiang D; Ti A; Li L; Dan Y; Yu C; Li W
    Oncol Rep; 2017 Mar; 37(3):1627-1636. PubMed ID: 28184929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.